Development of a Commercial Process for Deucravacitinib, a Deuterated API for TYK2 Inhibition
| العنوان: | Development of a Commercial Process for Deucravacitinib, a Deuterated API for TYK2 Inhibition |
|---|---|
| المؤلفون: | Daniel S. Treitler, Maxime C. Soumeillant, Eric M. Simmons, Dong Lin, Bahar Inankur, Amanda J. Rogers, Michael Dummeldinger, Sergei Kolotuchin, Collin Chan, Jun Li, Adam Freitag, Federico Lora Gonzalez, Michael J. Smith, Chris Sfouggatakis, Jianji Wang, Tamas Benkovics, Joerg Deerberg, James H. Simpson, Ke Chen, Steven Tymonko |
| المصدر: | Organic Process Research & Development. 26:1202-1222 |
| بيانات النشر: | American Chemical Society (ACS), 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Organic Chemistry, Physical and Theoretical Chemistry |
| تدمد: | 1520-586X 1083-6160 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::58f72fe26fb7a94028637ad1f8d4ac40 https://doi.org/10.1021/acs.oprd.1c00468 |
| حقوق: | CLOSED |
| رقم الأكسشن: | edsair.doi...........58f72fe26fb7a94028637ad1f8d4ac40 |
| قاعدة البيانات: | OpenAIRE |
Find this issue from the American Chemical Society | تدمد: | 1520586X 10836160 |
|---|